Warby Parker (WRBY)

• Market cap: $2.9B
• 1 day: -4.82%
• 5 days: -9.37%
• 1 month: -5.42%
• 3 months: 3.48%
• 6 months: 71.51%
• Year to date: -5.01%
• 1 year: 72.00%
• 5 years: -55.81%
• 10 years: -55.81%
• Sector: Healthcare
• Industry: Ophthalmic Goods

About: Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Employees: 3,491

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

143% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 23

48% more capital invested

Capital invested by funds: $1.61B [Q3] → $2.38B (+$772M) [Q4]

16% more funds holding

Funds holding: 197 [Q3] → 228 (+31) [Q4]

3% more call options, than puts

Call options by funds: $42.5M | Put options by funds: $41.3M

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

8% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 74

1.11% less ownership

Funds ownership: 97.76% [Q3] → 96.65% (-1.11%) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $20 17% downside
• Avg. target: $24 1% upside
• High target: $28 16% upside

7 analyst ratings

• positive: 3 43%
• neutral: 3 43%
• negative: 1 14%

Telsey Advisory Group Dana Telsey 49% 1-year accuracy 94 / 190 met price target	16% upside $28	Outperform Maintained	20 Feb 2025
Citigroup Paul Lejuez 61% 1-year accuracy 23 / 38 met price target	4% downside $23	Sell Downgraded	5 Feb 2025
Morgan Stanley Kimberly Greenberger 75% 1-year accuracy 3 / 4 met price target	4% downside $23	Equal-Weight Maintained	21 Jan 2025
Evercore ISI Group Mark Mahaney 89% 1-year accuracy 41 / 46 met price target	4% downside $23	In-Line Downgraded	17 Jan 2025
JMP Securities Nicholas Jones 75% 1-year accuracy 60 / 80 met price target	16% upside $28	Market Outperform Maintained	16 Dec 2024